-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Study Shows Sedentary Time Increases Cardiovascular Disease
Sedentary time negatively impacts heart health regardless of whether a person follows exercise guidelines.
-
Biomarkers May Help Predict Risk of Heart Failure in Patients With Atrial Fibrillation
A multicenter team led by the Brigham used patient data compiled from three large clinical trials to identify potential prognostic biomarkers that could be used to risk-stratify patients with atrial fibrillation based on their heart failure risk. First author Paul Haller, MD, PhD, discusses the study's implications.
-
CAD Prevalent in Patients With Type 2 MI but Usually Non-obstructive
Cian P. McCarthy, MBBCh, BAO, SM, James L. Januzzi, Jr., MD, and colleagues found in a prospective study that coronary artery disease affected 92% of patients with type 2 myocardial infarction, but despite a large overall burden of coronary plaque, 74% did not have hemodynamically significant focal stenosis.
Myocardial Infarction Contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital, Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School
Recent Article
Cardiorenal Biomarkers Predict Major Complications in Patients With Type 2 Diabetes and Chronic Kidney Disease
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Associate Professor of Medicine, Harvard Medical School
Recent Article
Lipoprotein(a), Oxidized Phospholipids Linked With CVD Severity in a Cohort Referred for Angiography
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.